You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Lupron

Showing 1 - 25 of 187
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Locally Advanced Salivary Gland Carcinoma, Metastatic Salivary Gland Carcinoma, Recurrent Salivary Gland Carcinoma Trial

Not yet recruiting
  • Locally Advanced Salivary Gland Carcinoma
  • +3 more
  • Biopsy
  • +3 more
  • (no location specified)
Jan 10, 2023

Castration-Sensitive Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 Trial in Duarte

Recruiting
  • Castration-Sensitive Prostate Carcinoma
  • +4 more
  • Abiraterone Acetate
  • +7 more
  • Duarte, California
    City of Hope Medical Center
Oct 7, 2022

Metastatic Prostate Cancer, Non-metastatic Prostate Cancer, Prostate Cancer Trial in Boston (Darolutamide, Abemaciclib, GNRH-A

Not yet recruiting
  • Metastatic Prostate Cancer
  • +2 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Nov 14, 2022

Prostate Adenocarcinoma Trial in Duarte (drug, radiation, other)

Recruiting
  • Prostate Adenocarcinoma
  • Leuprolide Acetate
  • +5 more
  • Duarte, California
    City of Hope Medical Center
Sep 14, 2022

Prostate Adenocarcinoma, Recurrent Prostate Carcinoma Trial in Houston (Abiraterone Acetate, Bicalutamide, Degarelix)

Active, not recruiting
  • Prostate Adenocarcinoma
  • Recurrent Prostate Carcinoma
  • Abiraterone Acetate
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 5, 2022

Prostate Adenocarcinoma, Prostate Cancer, High Risk Prostate Cancer Trial in Baltimore, Boston, Seattle (Enzalutamide,

Completed
Has Results
  • Prostate Adenocarcinoma
  • +2 more
  • Baltimore, Maryland
  • +3 more
Mar 30, 2022

PSA Level Greater Than Two, Stage IV Prostate Adenocarcinoma AJCC v7 Trial in Duarte, South Pasadena (drug, radiation, other)

Active, not recruiting
Has Results
  • PSA Level Greater Than Two
  • Stage IV Prostate Adenocarcinoma AJCC v7
  • Duarte, California
  • +1 more
Apr 4, 2022

Prostate Cancer Trial in Baltimore (DFMO, testosterone cypionate, Luteinizing hormone-releasing hormone (LHRH) analogue)

Not yet recruiting
  • Prostate Cancer
  • Baltimore, Maryland
    Johns Hopkins University: Sidney Kimmel Comprehensive Cancer Cen
Sep 22, 2023

Menopause Trial in Boston (Leuprolide Acetate, Fragmented sleep)

Active, not recruiting
  • Menopause
  • Leuprolide Acetate
  • Fragmented sleep
  • Boston, Massachusetts
    Brigham & Women's Hospital
Apr 8, 2022

Prostatic Tumors, Prostate Tumors, Prostate Cancer Trial in New York (5-Azacitidine, all trans retinoic acid, Lupron)

Completed
  • Prostatic Neoplasms
  • +2 more
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Aug 1, 2022

Leukemia, Multiple Myeloma, Myelodysplastic Syndrome Trial in New York (biological, procedure, radiation, drug)

Active, not recruiting
  • Leukemia
  • +3 more
  • Palifermin
  • +6 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 23, 2023

Prostate Cancer Trial (Lupron Depot)

Not yet recruiting
  • Prostate Cancer
  • Lupron Depot
  • (no location specified)
Dec 22, 2021

Polycystic Ovary Syndrome, Obstructive Sleep Apnea Trial in Chicago (Depot Lupron followed by estrogen plus , Depot Lupron

Active, not recruiting
  • Polycystic Ovary Syndrome
  • Obstructive Sleep Apnea
  • Depot Lupron followed by estrogen plus placebo
  • +2 more
  • Chicago, Illinois
    University of Chicago Department of Medicine, Section of Endocri
Oct 15, 2021

Prostate Adenocarcinoma, Obesity, Morbid Trial in Baltimore (device, behavioral, drug)

Withdrawn
  • Prostate Adenocarcinoma
  • Obesity, Morbid
  • Bead Block 300-500 um
  • +2 more
  • Baltimore, Maryland
    Johns Hopkins School of Medicine - Sidney Kimmel Comprehensive C
Apr 29, 2022

Prostate Cancer Trial in Cleveland (Leuprolide acetate, Apalutamide, Radical prostatectomy)

Completed
Has Results
  • Prostate Cancer
  • Leuprolide acetate
  • +2 more
  • Cleveland, Ohio
    Cleveland Clinic, Case Comprehensive Cancer Center
May 25, 2022

Prostate Cancer Trial in Washington, Baltimore (drug, procedure, radiation)

Completed
Has Results
  • Prostate Cancer
  • Leuprolide Acetate
  • +4 more
  • Washington, District of Columbia
  • +2 more
Jul 11, 2022

Endometriosis Trial in Quebec City (Leuprolide Oral Tablet 4-mg QD, Leuprolide Oral Tablet 4-mg BID, Leuprolide Depot)

Completed
Has Results
  • Endometriosis
  • Leuprolide Oral Tablet 4-mg QD
  • +3 more
  • Quebec City, Quebec, Canada
    inVentiv Health Clinique, Inc.
Jan 20, 2022

Prostate Cancer Metastatic Trial in New York (REGN2810, Degarelix, Leuprolide Acetate)

Recruiting
  • Prostate Cancer Metastatic
  • New York, New York
    Columbia University Irving Medical Center
Mar 22, 2022

Prostate Cancer Trial in Washington, Baltimore (Leuprolide Acetate, Docetaxel, Bicalutamide)

Active, not recruiting
  • Prostate Cancer
  • Leuprolide Acetate
  • +4 more
  • Washington, District of Columbia
  • +1 more
Mar 29, 2022

Hiv, Prophylaxis, Transgender Trial in Baltimore (Truvada alone, Truvada plus Leuprolide, Truvada plus Estradiol 1 mg)

Recruiting
  • Hiv
  • +2 more
  • Truvada alone
  • +4 more
  • Baltimore, Maryland
    Johns Hopkins School of Medicine Drug Development Unit
Mar 8, 2022

Cognitive Impairment, Executive Dysfunction, Endothelial Dysfunction Trial in Aurora, Boulder (Leuprolide acetate, Estradiol,

Completed
Has Results
  • Cognitive Impairment
  • +3 more
  • Leuprolide acetate
  • +3 more
  • Aurora, Colorado
  • +1 more
Dec 10, 2021

Prostatic Tumors, Pelvic Nodal Trial in San Francisco (Enzalutamide, Leuprolide, Intensity-Modulated Radiation Therapy)

Terminated
Has Results
  • Prostatic Neoplasms
  • Pelvic Nodal
  • San Francisco, California
    University of California San Francisco
Sep 14, 2021

Prostate Cancer Trial in Boston (Flutamide (Eulexin) and Lupron or Zoladex, External Beam Radiotherapy)

Completed
  • Prostate Cancer
  • Flutamide (Eulexin) and Lupron or Zoladex
  • External Beam Radiotherapy
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Dec 16, 2021

Biochemically Recurrent Prostate Carcinoma, Metastatic Prostate Carcinoma, Oligometastatic Prostate Carcinoma Trial in Houston

Withdrawn
  • Biochemically Recurrent Prostate Carcinoma
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 14, 2021

Gender Dysphoria in Children, Puberty, Bone Development Trial in Boston, Cincinnati (GnRH Agonist)

Recruiting
  • Gender Dysphoria in Children
  • +2 more
  • GnRH Agonist
  • Boston, Massachusetts
  • +1 more
Aug 24, 2021